July Is Hyperpigmentation & Melasma Awareness Month – Did You Know We Have a Curated Resource Just for You? As summer sun peaks, so does your patients’ concern about dark…
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
by Allison Sit Managed Healthcare Executive and Healio both wrote about a JDD study on the underrepresentation of racial and ethnic minority groups in vitiligo research. The study, “Racial and…
by Allison Sit Dermatology Advisor, Dermatology Times and Healio all covered recent articles in the Journal of Drugs in Dermatology. One study, “Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the…
Click Here to View Video Abstract Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesions. Short-term…
The dermatology trade press featured several JDD articles about pigmentary disorders in recent weeks. Dermatology Times reported on a JDD study in its article about comorbidities in vitiligo. The study,…
Melasma is a dermatologic condition that causes brown or gray patches to appear on the skin, typically on the face, neck, chest, and arms. It is a chronic condition that…